Latest / Decera Clinical Education Oncology Podcast
The Latest Advances and Guidance in Nonmetastatic Castration-Resistant Prostate Cancer
In this episode, Karim Fizazi, MD, PhD, and Alicia K. Morgans, MD, MPH, discuss the clinical implications of the latest data on androgen receptor–targeting agents in the treatment of patients with nonmetastatic castration-resistant prostate cancer (CRPC). Topics include:
Updated safety and patient preference data from the ARAMIS and ODENZA trials
Choice of apalutamide, darolutamide, and enzalutamide
Counseling patients on adverse events
Managing patients with asymptomatic nonmetastatic CRPC
Presenters:
Karim Fizazi, MD, PhD
Full Professor
Cancer Medicine
Gustave Roussy
Villejuif, France…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.